Page last updated: 2024-11-02

pantoprazole and Infections

pantoprazole has been researched along with Infections in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Infections: Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.

Research Excerpts

ExcerptRelevanceReference
"Pantoprazole was the most commonly prescribed drug and appeared in 63% of all orders."1.62Pattern of systemic antibiotic use and potential drug interactions: Evaluations through a point prevalence study in Ankara University Hospitals. ( Akdemir Kalkan, İ; Akyol, B; Azap, A; Çınar, G; Memikoğlu, KO; Onay Beşikçi, A; Pehlivanlı, A; Topaloğlu, İE; Ürkmez, F, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Akdemir Kalkan, İ1
Çınar, G1
Pehlivanlı, A1
Ürkmez, F1
Topaloğlu, İE1
Akyol, B1
Onay Beşikçi, A1
Azap, A1
Memikoğlu, KO1

Other Studies

1 other study available for pantoprazole and Infections

ArticleYear
Pattern of systemic antibiotic use and potential drug interactions: Evaluations through a point prevalence study in Ankara University Hospitals.
    Turkish journal of medical sciences, 2021, 04-30, Volume: 51, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Child; Comorbidity; Cross Infection; Cr

2021